|
|
||||||||
Clinical Chemistry, Vol 27, 1704-1707, Copyright © 1981 by American Association for Clinical Chemistry
P Rosenthal, N Blanckaert, PM Kabra and MM Thaler
This newly developed and highly specific and sensitive procedure was applied to the determination of unconjugated bilirubin and its ester conjugates in rat serum and human amniotic fluid. Bilirubin conjugates in biological samples are converted to methyl esters by alkaline methanolysis, extracted into chloroform, and the unconjugated bilirubin and esterified pigment derivatives are fractionated by "high- performance" liquid chromatography. The separated pigments are measured spectrophotometrically. Bilirubin and its mono- and di-conjugates are readily quantitated, even in previously undetectable concentrations. Linearity was established from 0.07 to 121.2 mumol/L for unconjugated bilirubin, 0.07 to 34.6 mumol/L for the C-8 monoconjugate, 0.06 to 69.3 mumol/L for the C-12 monoconjugate, and 0.17 to 43.7 mumol/L for the di- conjugate fraction. The detection limit was 0.03 mumol/L for unconjugated bilirubin and for each monoconjugate, and 0.1 mumol/L for the di-conjugated pigment.
The following articles in journals at HighWire Press have cited this article:
![]() |
K. Foster, J. Moore, K. Hankins, C. A. Parvin, and A. M. Gronowski Effect of Blood Contamination on Delta 450 Bilirubin Measurement: An in Vitro Comparison of Two Corrective Methods Clin. Chem., August 1, 2004; 50(8): 1420 - 1422. [Full Text] [PDF] |
||||
![]() |
R. Cariappa, C. A. Parvin, and A. M. Gronowski Bilirubin in Amniotic Fluid Does Not Interfere with the Abbott TDx FLM II Assay Clin. Chem., June 1, 2003; 49(6): 986 - 987. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |